Intershop Holding Stock (OTC:ISZNF), Trade Ideas

Intershop Holding AG is a Switzerland-based company that is principally engaged in Swiss commercial real estate business. The company's property portfolio is mainly located in the main business regions of Switzerland, especially in Zurich, Bern, and Geneva. The company's property portfolio consists of office property, education property, property for light industrial/logistics, retail property, residential property, and parking property, with office property and property for light industrial/logistics accounting for over two thirds of the total property portfolio.

INTERSHOP HLDGS AG NEW by Intershop Holdings AG

Intershop Holding AG

Sanjay will remain with WNS in an advisory role until April 24, 2025 to help ensure a seamless transition.

News

Management

WNS Names Arijit Sen, Its Corporate Financial Controller, As CFO Effective July 25, 2024, Succeeding Sanjay Puria Who Has Chosen To Step Down For Family Reasons

Guidance

Health Care

General

West Pharmaceutical Services Reaffirms full-year 2024 net sales guidance of $3B-$3.025B Versus Consensus Of $3.01B

Tri Pointe Homes Sees Q2 Deliveries 1,500-1,600 Homes At Avg. Sales Price $670K-$680K

Oshkosh Raises FY24 Adj. EPS Outlook To Be In The Range Of $11.25 vs $10.36 Est.

FirstCash Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.52 by 1.97 percent. This is a 24 percent increase over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $836.370 million which missed the analyst consensus estimate of $846.074 million by 1.15 percent. This is a 9.65 percent increase over sales of $762.739 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

FCFS

FirstCash Hldgs Q1 2024 Adj EPS $1.55 Beats $1.52 Estimate, Sales $836.370M Miss $846.074M Estimate

The&nbsp;total consideration of up to &euro;275 million, consisting of an upfront cash payment of &euro;190 million and up to &euro;85 million in potential earnout payments based on the Rare Diseases business achieving certain sales milestones.&nbsp;
Following the information and consultation process with HRA Pharma Works Council in&nbsp;France, Perrigo would be able to exercise the put option granted by ESTEVE and enter into a definitive agreement with ESTEVE for the sale of the Rare Diseases business. The proposed final transaction is expected to close during the&nbsp;third quarter&nbsp;of 2024

Asset Sales

PRGO

Perrigo Secures Binding Offer To Divest Its HRA Pharma Rare Diseases Business For Up To €275M

Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) reported quarterly earnings of $2.25 per share which beat the analyst consensus estimate of $2.17 by 3.69 percent. This is a 1.35 percent increase over earnings of $2.22 per share from the same period last year. The company reported quarterly sales of $9.105 billion which beat the analyst consensus estimate of $9.030 billion by 0.83 percent. This is a 2.72 percent increase over sales of $8.864 billion the same period last year.

Honeywell Intl Q1 2024 Adj EPS $2.25 Beats $2.17 Estimate, Sales $9.105B Beat $9.030B Estimate

Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) reported quarterly earnings of $3.29 per share which beat the analyst consensus estimate of $3.24 by 1.54 percent. The company reported quarterly sales of $2.341 billion which missed the analyst consensus estimate of $2.373 billion by 1.37 percent. This is a 4.32 percent increase over sales of $2.244 billion the same period last year.

Willis Towers Watson Q1 2024 Adj EPS $3.29 Beats $3.24 Estimate, Sales $2.341B Miss $2.373B Estimate

WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.06 by 5.66 percent. This is a 7.69 percent increase over earnings of $1.04 per share from the same period last year. The company reported quarterly sales of $325.90 million which beat the analyst consensus estimate of $323.84 million by 0.64 percent. This is a 6.85 percent increase over sales of $305.00 million the same period last year.

WNS (Hldgs) Q4 Adj $1.12 Beats $1.06 Estimate, Sales $325.90M Beat $323.84M Estimate

Oshkosh Q1 2024 Adj EPS $2.89 Beats $2.25 Estimate, Consolidated Net Sales $2.54B Beat $2.484B Estimate

Wolfe Research analyst Deepak Mathivanan maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Outperform and lowers the price target from $530 to $500.

Price Target

Analyst Ratings

Wolfe Research Maintains Outperform on Meta Platforms, Lowers Price Target to $500

West Pharmaceutical Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate of $1.26 by 23.81 percent. This is a 21.21 percent decrease over earnings of $1.98 per share from the same period last year. The company reported quarterly sales of $695.400 million which beat the analyst consensus estimate of $670.303 million by 3.74 percent. This is a 2.96 percent decrease over sales of $716.600 million the same period last year.

West Pharmaceutical Servs Q1 2024 Adj EPS $1.56 Beats $1.26 Estimate, Sales $695.400M Beat $670.303M Estimate

Escalade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESCA#NASDAQ">ESCA</a>) reported quarterly earnings of $0.13 per share. This is a 285.71 percent increase over losses of $(0.07) per share from the same period last year. The company reported $57.30 million in sales this quarter. This is a 0.66 percent increase over sales of $56.93 million the same period last year.

ESCA

Escalade Q1 EPS $0.13 Up From $(0.07) YoY, Sales $57.30M Up From $56.93M YoY

Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.45 by 24.44 percent. This is a 3.45 percent decrease over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $10.765 billion which beat the analyst consensus estimate of $10.743 billion by 0.20 percent. This is a 9.16 percent decrease over sales of $11.851 billion the same period last year.

Dow Q1 2024 Adj EPS $0.56 Beats $0.45 Estimate, Sales $10.765B Beat $10.743B Estimate

Tri Pointe Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPH#NYSE">TPH</a>) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.76 by 35.53 percent. The company reported quarterly sales of $926.208 million which beat the analyst consensus estimate of $875.187 million by 5.83 percent. This is a 20.16 percent increase over sales of $770.785 million the same period last year.

Tri Pointe Homes Q1 2024 GAAP EPS $1.03 Beats $0.76 Estimate, Total Revenue $926.208M Beat $875.187M Estimate

Berenberg analyst Peter Richardson initiates coverage on Lloyds Banking Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYG#NYSE">LYG</a>) with a Hold rating and announces Price Target of $2.75.

Initiation

Berenberg Initiates Coverage On Lloyds Banking Group with Hold Rating, Announces Price Target of $2.75

The lead marketer for&nbsp;Apple Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Vision Pro headset,&nbsp;Frank Casanova, has retired, just months <a href="https://www.benzinga.com/news/24/04/38136012/apple-vision-pros-immersive-content-library-to-expand-with-a-dinosaur-film-iphone-16-to-further-boos">after the headset&#8217;s launch</a> and amid a significant drop in demand.
What Happened: Casanova who departed from the tech giant last week had been with Apple for 36 years. He has played a pivotal role in the marketing of the Vision Pro headset along with helping to lead the expansion of the iPhone to new carriers, <a href="https://www.bloomberg.com/news/articles/2024-04-24/apple-s-lead-marketer-for-new-vision-pro-headset-retires?srnd=technology-vp">reported</a>&nbsp;Bloomberg, citing his LinkedIn page. 
The Vision Pro was made available for purchase in early February with a base price of $3,499. Casanova participated in its launch at Apple&#8217;s flagship retail store in the Grove shopping mall in Los Angeles, accompanied by services chief Eddy Cue. 
Dan Riccio, the executive responsible for the development of the device, is approaching retirement.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The retirement of key personnel comes at a critical time for Apple&#8217;s headset business. The Cupertino, California-based tech giant has plans to <a href="https://www.benzinga.com/news/24/03/37910624/apple-sets-sight-on-china-vision-pro-headset-launching-this-year">expand its market to China</a>, a move confirmed by CEO&nbsp;Tim Cook&nbsp;last month, in a video shared on a CCTV account on Weibo.
However, the demand for the Vision Pro has reportedly&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38397921/apple-in-trouble-tim-cook-reportedly-cuts-vision-pro-shipment-forecasts-by-up-to-50">fallen sharply</a>, leading to a significant drop in shipment forecasts. This has forced Apple to re-evaluate its headset business strategy, as noted by analyst&nbsp;Ming-Chi Kuo. The company has reportedly revised its Vision Pro shipment estimates to 400,000-450,000 units for this year, down from the initial 700,000-800,000 units.&nbsp;
Apple&#8217;s struggles in China are not limited to the headset market. The company also faced a <a href="https://www.benzinga.com/government/24/03/37941515/apples-iphone-sales-faces-sharp-decline-in-china-amid-rising-competition">sharp decline in iPhone sales</a> in the country, with a 33% drop in February compared to the last year. 
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/government/24/04/38350596/former-gop-hopeful-nikki-haley-joins-calls-for-tiktok-ban-to-stop-infiltration-of-chinese-communist?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple Vision Pro: Why Some Users Have Decided To Return The Headset While Others Can&#8217;t Imagine Going Back Living The Same Way</a>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image courtesy &#8211; Apple

Tech

Media

AAPL

Apple's Top Marketer For Vision Pro Bids Farewell After 36 Years At Cupertino Amid Demand Slump

-Reuters Citing Russian News Agencies Tass, RIA

Belarusian President Lukashenko: Several Dozens Of Russian Nuclear Weapons Deployed In Belarus;  In Case Of Attack On Belarus, Minsk And Moscow Will Instantly Respond With All Kinds Of Weapon

Needham analyst Mike Matson maintains Conmed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) with a Buy and lowers the price target from $129 to $107.

CNMD

Needham Maintains Buy on Conmed, Lowers Price Target to $107

TD Cowen analyst Andrew Charles maintains Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) with a Buy and raises the price target from $3400 to $3500.